Gabriele E. Bugaisky

Array ( [id] => 3811996 [patent_doc_number] => 05710035 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-20 [patent_title] => 'Human elastase IV' [patent_app_type] => 1 [patent_app_number] => 8/270584 [patent_app_country] => US [patent_app_date] => 1994-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7800 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/710/05710035.pdf [firstpage_image] =>[orig_patent_app_number] => 270584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3742057 [patent_doc_number] => 05801037 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-01 [patent_title] => 'Expression of signal-peptide-free staphylokinases' [patent_app_type] => 1 [patent_app_number] => 8/256261 [patent_app_country] => US [patent_app_date] => 1994-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 20412 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/801/05801037.pdf [firstpage_image] =>[orig_patent_app_number] => 256261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3597475 [patent_doc_number] => 05559019 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-24 [patent_title] => 'Protein serine kinase, SRPK1' [patent_app_type] => 1 [patent_app_number] => 8/264002 [patent_app_country] => US [patent_app_date] => 1994-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 44 [patent_no_of_words] => 16468 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/559/05559019.pdf [firstpage_image] =>[orig_patent_app_number] => 264002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3726588 [patent_doc_number] => 05635182 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Method of detecting ligand interactions' [patent_app_type] => 1 [patent_app_number] => 8/260582 [patent_app_country] => US [patent_app_date] => 1994-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16630 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635182.pdf [firstpage_image] =>[orig_patent_app_number] => 260582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3489518 [patent_doc_number] => 05470825 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-28 [patent_title] => 'Basophil granule proteins' [patent_app_type] => 1 [patent_app_number] => 8/259564 [patent_app_country] => US [patent_app_date] => 1994-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5891 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/470/05470825.pdf [firstpage_image] =>[orig_patent_app_number] => 259564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3475573 [patent_doc_number] => 05432070 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-07-11 [patent_title] => 'Cloned N-Methylhydantoinase' [patent_app_type] => 1 [patent_app_number] => 8/258614 [patent_app_country] => US [patent_app_date] => 1994-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 4550 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/432/05432070.pdf [firstpage_image] =>[orig_patent_app_number] => 258614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3854817 [patent_doc_number] => 05705358 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'Process for producing/secreting a protein by a transformed mould using expression/secretion regulating regions derived from a aspergillus endoxylanase II gene' [patent_app_type] => 1 [patent_app_number] => 8/244686 [patent_app_country] => US [patent_app_date] => 1994-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 90 [patent_no_of_words] => 10172 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705358.pdf [firstpage_image] =>[orig_patent_app_number] => 244686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3724176 [patent_doc_number] => 05700638 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-23 [patent_title] => 'Cell death regulator' [patent_app_type] => 1 [patent_app_number] => 8/248819 [patent_app_country] => US [patent_app_date] => 1994-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 59 [patent_no_of_words] => 36573 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/700/05700638.pdf [firstpage_image] =>[orig_patent_app_number] => 248819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3472679 [patent_doc_number] => 05476839 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-19 [patent_title] => 'Basophil granule proteins' [patent_app_type] => 1 [patent_app_number] => 8/245853 [patent_app_country] => US [patent_app_date] => 1994-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10447 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 465 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/476/05476839.pdf [firstpage_image] =>[orig_patent_app_number] => 245853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3521473 [patent_doc_number] => 05527555 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-18 [patent_title] => 'Brazzein sweetener' [patent_app_type] => 1 [patent_app_number] => 8/242655 [patent_app_country] => US [patent_app_date] => 1994-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3389 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/527/05527555.pdf [firstpage_image] =>[orig_patent_app_number] => 242655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3556171 [patent_doc_number] => 05501970 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-26 [patent_title] => 'Nucleotide sequences coding for ribosome inactivating proteins' [patent_app_type] => 1 [patent_app_number] => 8/182114 [patent_app_country] => US [patent_app_date] => 1994-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 3318 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/501/05501970.pdf [firstpage_image] =>[orig_patent_app_number] => 182114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3607534 [patent_doc_number] => 05589384 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-31 [patent_title] => 'Fusion proteins' [patent_app_type] => 1 [patent_app_number] => 8/237716 [patent_app_country] => US [patent_app_date] => 1994-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 6185 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/589/05589384.pdf [firstpage_image] =>[orig_patent_app_number] => 237716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3601002 [patent_doc_number] => 05578480 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-26 [patent_title] => 'Methods for the isolation and purification of the recombinantly expressed chondroitinase I and II enzymes from P. vulgaris' [patent_app_type] => 1 [patent_app_number] => 8/233008 [patent_app_country] => US [patent_app_date] => 1994-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 10161 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/578/05578480.pdf [firstpage_image] =>[orig_patent_app_number] => 233008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3659742 [patent_doc_number] => 05648256 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-15 [patent_title] => 'Gene encoding a polypeptide having nitrile hydratase activity, a transformant containing the gene and a process for the production of amides using the transformant' [patent_app_type] => 1 [patent_app_number] => 8/233146 [patent_app_country] => US [patent_app_date] => 1994-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4780 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/648/05648256.pdf [firstpage_image] =>[orig_patent_app_number] => 233146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3843059 [patent_doc_number] => 05766605 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Treatment of autonomic nerve dysfunction with botulinum toxin' [patent_app_type] => 1 [patent_app_number] => 8/228132 [patent_app_country] => US [patent_app_date] => 1994-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 5575 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/766/05766605.pdf [firstpage_image] =>[orig_patent_app_number] => 228132 [rel_patent_id] =>[rel_patent_doc_number] =>)